Timothee Chalamet hosts and takes to the stage as the musical guest for Saturday Night Live on January 24, as the sketch-comedy shows continues its 50th season. You can watch the A Complete ...

The Scram 440 marks the end of the 411 cc displacement on Royal Enfield bikes, but the motor continues to live on in an upgraded avatar. Tata Punch was the bestselling car in India in 2024 and now ...

Form GSTR-2A- Details of auto drafted supplies Form GSTR-2B- Auto drafted ITC statement Interestingly, both the above-referred statement reflects details of inward supplies as well as details of an ...

We advise you to avoid simply saving the image previews you see below. These wallpaper previews are compressed and optimized for improved website performance. Instead, you should click the button ...

The state of Maryland is facing a $3 billion budget shortfall. Gov. Wes Moore has announced significant budget cuts and has said he will hike taxes on the wealthiest residents to increase ...

A total of P4.2 billion was appropriated for the new Senate building in the 2025 national budget, bringing the total allocation to the structure to P23.5 billion since 2018. In Mav Gonzales’ Wednesday ...

The GSTR-2B (input tax credit) statement will now be generated two days later on Thursday, January 16, from the originally scheduled date of January 14, for the December 2024 tax period.

'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...

Colossal Biosciences, the company that’s famously on a mission to bring back the woolly mammoth and two other extinct species, has raised a $200 million Series C at a $10.2 billion valuation ...

The Canadian government has approved Bunge Ltd.'s $8.2-billion US acquisition of Viterra Ltd., but the Agriculture Producers Association of Saskatchewan (APAS) says more action is needed to ...

(NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced positive data from a Phase 2b clinical trial ...